Codexis (CDXS) Receivables - Other (2010 - 2026)
Codexis (CDXS) posted quarterly Receivables - Other of $1.3 million for Q1 2026, down 66.41% year-over-year from $3.8 million in Q1 2025, and down 12.64% quarter-over-quarter from $1.5 million in Q4 2025.
Codexis (CDXS) Receivables - Other (2010 - 2026) Analysis & Trends
Codexis' Receivables - Other history runs 15 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Receivables - Other fell 66.41% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (down 66.41% YoY), while the FY2025 annual figure was $1.7 million, down 45.73% from the prior year.
- Receivables - Other for Q1 2026 stood at $1.3 million, down from $1.5 million in the prior quarter.
- The five-year high for Receivables - Other was $10.7 million in Q2 2023, with the low at $1.3 million in Q1 2026.
- The 5-year median for Receivables - Other is $5.7 million (2023), against an average of $5.8 million.
- The sharpest annual moves came in 2023 and 2024: Receivables - Other jumped 41.16% in 2023, then tumbled 67.61% in 2024.
- Codexis' Receivables - Other stood at $7.0 million in 2022, then surged by 41.16% to $9.9 million in 2023, then sank by 67.61% to $3.2 million in 2024, then tumbled by 53.87% to $1.5 million in 2025, then declined by 12.64% to $1.3 million in 2026.
- Business Quant data shows CDXS's Receivables - Other at $1.3 million in Q1 2026, $1.5 million in Q4 2025, and $2.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Codexis | 146.14 Mn | 91.22 Mn | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.38 Mn |
| Jun 30, 2026 | 1.38 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Mar 31, 2026 | 1.29 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 3.32 Mn |
| Jun 30, 2025 | 3.32 Mn |
| Mar 31, 2025 | 3.85 Mn |
| Mar 31, 2025 | 3.85 Mn |
| Dec 31, 2024 | 3.21 Mn |
| Dec 31, 2024 | 3.21 Mn |
| Sep 30, 2024 | 4.79 Mn |
| Sep 30, 2024 | 4.79 Mn |
| Jun 30, 2024 | 5.55 Mn |
| Jun 30, 2024 | 5.55 Mn |
| Mar 31, 2024 | 6.37 Mn |
| Mar 31, 2024 | 6.37 Mn |